Life Sciences

A new mega campus for ag-tech in North Carolina aims to foster solutions to world hunger and lead the way to a more urbanized Research Triangle Park.

The US Trade Representative and PhRMA are too.

As the 2016 Life Sciences Outlook from JLL reported in December, the Big Apple's life sciences cluster is growing rapidly.

One star among many stellar institutes in Greater San Diego shows the economic as well as scientific influence of research.

A global medical products distributor and healthcare services provider chooses to grow where it was first planted 135 years ago.

A new CBRE report on 'Eds & Meds' shows the ultimate economic vital sign may be stability itself.

A number of new districts, neighborhoods, incubators and campuses are taking shape across the United States.

Two new rankings assess US states by overall well-being and by healthcare system flexibility. See where they overlap, and where they don't.

In deciding to invest in the UK, Novo Nordisk finds that hundreds of years of history weigh a lot.

New growth at the Hong Kong Science Park is just one aspect of the city's innovation-driven ecosystem.

New reports on obesity and heart attack incidence could be your guides.

The company is the latest explorer seeking discovery in the DNA of South San Francisco.

Quick: Where were both insulin and stem cells discovered? If you said Canada's largest city, give yourself a red maple leaf.

Companies from France and Ireland add further ballast to an already strong bioscience ecosystem.

But suburban, second-tier and submarket options beckon with opportunity.

In the midst of a global growth strategy, a German pharmaceutical company plans to make a major investment in Des Plaines, Illinois.

A Maryland company will work with a Chinese firm to deliver manufactured lungs for transplants via drone.

In October 2014, UK-based Vernalis Therapeutics Inc. established its first-ever US base in Berwyn in Chester County, Pennsylvania

Colombia's decision to force a price reduction on a major moneymaker from Novartis is a tough pill to swallow.

A maker of respiratory products expands in the Keystone State following a merger.

A new report offers smart site selection guidance for companies amid a roiling regulatory climate in Europe.

NextDecade CEO Kathleen Eisbrenner brings a world of experience to the world of LNG.

Medical devices are a big deal in Minnesota. The cluster's attractiveness is central to a big $25-billion deal announced this week.

Paul Allen and his city take the reins in pursuing global life sciences frontiers.